DHR Health Institute for Research and Development
Edinburg, Texas, United States
Research institute in Edinburg, Texas
5323 S McColl Rd, Edinburg, TX 78539
About DHR Health Institute for Research and Development
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at DHR Health Institute for Research and Development
During the past decade, DHR Health Institute for Research and Development conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on
average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
1994-09-01
2006-07-01
Completed
270
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
2001-05-01
2010-12-01
Completed
A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
2000-12-01
2003-01-01
Completed
A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients
2000-12-01
2003-01-01
Completed
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2005-09-01
2015-04-01
Completed
1,873
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "DHR Health Institute for Research and Development" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "Sohail Rao" with 2 trials
sponsored, "Adaptive Phage Therapeutics, Inc." with 1 trials sponsored, "BioNTech SE" with 1 trials sponsored and "DHR Health Institute for Research and Development"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "DHR Health Institute for Research and Development"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at DHR Health Institute for Research and Development
According to Clinical.Site data, the most researched conditions in "DHR Health Institute for Research and Development" are
"COVID-19" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Colon Adenocarcinoma" (2 trials), "Small Lymphocytic Lymphoma" (2 trials) and "Ann Arbor Stage III Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "DHR Health Institute for Research and Development" in a lesser frequency.
Clinical Trials Intervention Types at DHR Health Institute for Research and Development
Most popular intervention types in "DHR Health Institute for Research and Development" are "Biological" (9 trials), "Drug" (8 trials), "Other" (8 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Biospecimen Collection" (4 trials), "Computed Tomography" (4 trials), "Quality-of-Life Assessment" (4 trials), "Atezolizumab" (3 trials) and "Fluorouracil" (3 trials). Other intervention names were less common.
Clinical Trials Genders at DHR Health Institute for Research and Development
The vast majority of trials in "DHR Health Institute for Research and Development" are
15 trials for "All" genders.
Clinical Trials Status at DHR Health Institute for Research and Development
Currently, there are NaN active trials in "DHR Health Institute for Research and Development".
undefined are not yet recruiting,
9 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in DHR Health Institute for Research and Development,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in DHR Health Institute for Research and Development, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".